Bristol Myers Squibb’s $286 Million Acquisition of 2seventy bio

Leila Ahmed
Tagged:

Covington & Burling advised Bristol Myers Squibb on the deal, and Goodwin Procter advised 2seventy bio.Bristol Myers Squibb (NYSE: BMY) (“BMS”) announced its merger agreement to…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here